Israel's Biotech Innovation
Israel's "Startup Nation" reputation extends to biotechnology, with numerous organ-on-chip and organoid companies emerging from its strong research ecosystem.
FDA-Harmonized Approach
MOH Israel closely aligns with FDA regulatory standards:
- Reference Approval: FDA-approved NAMs recognized with documentation
- Innovation Pathway: Expedited review for breakthrough technologies
- Scientific Advice: Pre-submission meetings available
Israeli NAMs Companies
- Quris-AI: AI-powered clinical prediction platform
- Tissue Dynamics: Organ-on-chip systems
- Weizmann Institute: Leading organoid research